3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

Completed · Phase 3 · Has a placebo group

Conditions studied: Post-menopausal Osteoporosis

In brief

This second extension will evaluate the efficacy and long term safety of zoledronic acid in women with post-menopausal osteoporosis

Key facts

Study ID

NCT00718861

Run by

Novartis Pharmaceuticals

People needed

190

Starts

2008-05-01

Expected to finish

2013-04-01

Last updated by the study team

2014-10-09

Who can join

Age: 65 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women who have received the 4th and 6th dose of zoledronic acid in study CZOL446H2301E1

You may not qualify if…

• Poor kidney, eye, liver health
• Use of certain therapies for osteoporosis in study CZOL446H2301E1
• Abnormal calcium levels
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Novartis Investigative Site — Lakewood, Colorado, United States
• Novartis Investigative Site — Gainesville, Georgia, United States
• Novartis Investigative Site — Indiamapolis, Indiana, United States
• Novartis Investigative Site — Bangor, Maine, United States
• Novartis Investigative Site — Albuquerque, New Mexico, United States
• Novartis Investigative Site — Fargo, North Dakota, United States
• Novartis Investigative Site — Pittsburgh, Pennsylvania, United States
• Novartis Investigative Site — Richmond, Virginia, United States
• Novartis Investigative Site — Seattle, Washington, United States
• Novartis Investigative Site — Buenos Aires, Buenos Aires, Argentina
• Novartis Investigative Site — Caba, Buenos Aires, Argentina
• Novartis Investigative Site — Quilmes, Buenos Aires, Argentina
• Novartis Investigative Site — St Leonards, New South Wales, Australia
• Novartis Investigative Site — Geelong, Victoria, Australia
• Novartis Investigative Site — Parkville, Victoria, Australia
• Novartis Investigative Site — Ghent, Belgium
• Novartis Investigative Site — Leuven, Belgium
• Novartis Investigative Site — Vancouver, British Columbia, Canada
• Novartis Investigative Site — Montreal, Quebec, Canada
• Novartis Investigative Site — Sainte-Foy, Quebec, Canada
• Novartis Investigative Site — Barranquilla, Colombia
• Novartis Investigative Site — Bogotá, Colombia
• Novartis Investigative Site — Medellín, Colombia
• Novartis Investigative Site — Helsinki, Finland
• Novartis Investigative Site — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.